Thomas Catinazzo
Fortuna: 2 M $ al 30/09/2026
Fortuna: 2 M $ al 30/09/2026
Thomas Catinazzo is currently Chief Financial Officer at Relay Therapeutics, Inc. since 2022.
Formerly, Mr. Catinazzo was Vice President-Financial Planning & Analysis at Foundation Medicine, Inc. from 2017 to 2018.
Education includes an undergraduate degree from Boston College.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
RELAY THERAPEUTICS, INC. 0,05 % | 06/10/2026 | 105.134 ( 0,05 % ) | 2 M $ | 30/09/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| RELAY THERAPEUTICS, INC. | Director Financiero/CFO | 01/04/2018 |
| Empresas | Cargo | Fin |
|---|---|---|
| FOUNDATION MEDICINE INC | Corporate Officer/Principal | 01/04/2018 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 3 |
|---|---|
Boston College
Boston College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Foundation Medicine, Inc.
Foundation Medicine, Inc. Medical/Nursing ServicesHealth Services Provides diagnostic solutions for cancer care | Health Services |
Relay Therapeutics, Inc.
Relay Therapeutics, Inc. BiotechnologyHealth Technology Operates as clinical-stage precision medicine company, which focus on enhancing small molecule therapeutic discovery in targeted oncology | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.